Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
AOTI, Inc. ( (GB:AOTI) ) just unveiled an announcement.
AOTI, Inc. announced the results of its Annual General Meeting held on June 25, 2025, where all ten proposed resolutions were passed, including the appointment of several new directors and the re-appointment of Grant Thornton as the company’s auditor. The meeting also saw the stepping down of Anthony Moffat from his director role, although he will continue as COO. These developments could strengthen AOTI’s leadership and operational strategies, potentially enhancing its market position and stakeholder confidence.
More about AOTI, Inc.
AOTI, Inc., founded in 2006 and based in Oceanside, California, US, and Galway, Ireland, provides innovative solutions for severe and chronic wound care globally. The company’s patented non-invasive Topical Wound Oxygen (TWO2®) therapy significantly reduces hospitalizations and amputations related to Diabetic Foot Ulcers (DFUs) and is approved by multiple international regulatory bodies.
Average Trading Volume: 37,571
Technical Sentiment Signal: Strong Sell
Current Market Cap: £95.72M
For an in-depth examination of AOTI stock, go to TipRanks’ Overview page.